The DOI matches its Crossref record; 222 of the 222 references it cites were found in a registry or an index.
ESC/EAS Guidelines for the management of dyslipidaemias
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“There are also other reports suggesting that the outcome of cerebral infarction that occurs during the course of treatment with statins is satisfactory866), and that cerebral infarction risk increases as a result of discontinuing statin treatment867).”
From Japan Atherosclerosis Society (JAS) guidelines for prevention of atherosclerotic cardiovascular diseases 2017 (2018) · cites this paper as [867]
Citations
Cites
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
Alberti, K. G. M. M., Eckel, R. H., Grundy, S. M., Zimmet, P. Z., Cleeman, J. I., Donato, K. A., Fruchart, J.-C., James, W. P. T., Loria, C. M., & Smith, S. C. (2009) · Circulation · doi:10.1161/circulationaha.109.192644 · Cited by 14,860
General Cardiovascular Risk Profile for Use in Primary Care: The Framingham Heart Study
D’Agostino, R. B., Vasan, R. S., Pencina, M. J., Wolf, P. A., Cobain, M., Massaro, J. M., & Kannel, W. B. (2008) · Circulation · doi:10.1161/circulationaha.107.699579 · Cited by 7,491
Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia
Shepherd, J., Cobbe, S. M., Ford, I., Isles, C. G., Lorimer, A. R., Macfarlane, P. W., McKillop, J. H., & Packard, C. J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511163332001 · Cited by 7,449
Sacks, F. M., Pfeffer, M. A., Moye, L. A., Rouleau, J. L., Rutherford, J. D., Cole, T. G., Brown, L., Warnica, J. W., Arnold, J. M. O., Wun, C.-C., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199610033351401 · Cited by 7,439
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
Ridker, P. M., Danielson, E., Fonseca, F. A. H., Genest, J., Gotto, A. M., Kastelein, J. J. P., Koenig, W., Libby, P., Lorenzatti, A. J., MacFadyen, J. G., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0807646 · Cited by 6,674
Cholesterol Treatment Trialists' (CTT) Collaboration (2010) · The Lancet · doi:10.1016/s0140-6736(10)61350-5 · Cited by 6,550
Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project
Conroy, R. (2003) · European Heart Journal · doi:10.1016/s0195-668x(03)00114-3 · Cited by 5,290
(1998) · New England Journal of Medicine · doi:10.1056/nejm199811053391902 · Cited by 5,261
Flagged first, then by citations
Research works printed but not linked: 4
- Abumweis SS, Barake R, Jones PJ. Plant sterols/stanols as cholesterol lowering agents: a meta-analysis of randomized controlled trials. Food Nutr Res 2008;52, doi:10.3402/fnr.v52io.1811. · DOI
- 2005, Process for the assessment of scientific support for claims on foods: consensus on criteria, Eur J Nutr, 44, I/5
- Poulter, 1999, The impact of micronized fenofibrate on lipid subfractions and on reaching HDL-target levels in 7,098 patients with dyslipidaemia, Br J Cardiol, 6, 682
- DeMott K, Nherera L, Shaw EJ, Minhas R, Humphries SE, Kathoria M, Ritchie G, Nunes V, Davies D, Lee P, McDowell I, Neil A, Qureshi N, Rowlands P, Seed M, Stracey H, Thorogood M, Watson M. Clinical guidelines and evidence review for familial hypercholesterolaemia: the identification and management of adults and children with familial hypercholesterolaemia. London: National Collaborating Centre for Primary Care and Royal College of General Practitioners; 2008.
Cited by
Sorted by citations
Items 101–192 of 192
Hypolipidemic drugs in elderly subjects: Indications and limits
Gazzola, K., & Vigna, G. B. (2016) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2016.07.008 · Cited by 9
Real-World Data to Identify Hypercholesterolemia Patients on Suboptimal Statin Therapy
Kajinami, K., Ozaki, A., Tajima, Y., Yamashita, S., Arai, H., & Teramoto, T. (2018) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.46201 · Cited by 9
Cai, X., Luo, D., Liu, S., Li, R., Lu, Y., Li, M., & Qiu, S. (2021) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2020.629 · Cited by 8
Fenofibrate modified-release pellets with lag phase and high oral bioavailability
Li, F., Zheng, X. S., Bao, Y., Chen, T., Zeng, J., Xu, X.-L., Yan, C., & Feng, L. (2018) · Drug Design Development and Therapy · doi:10.2147/dddt.s179266 · Cited by 8
Malalla, Z. H. A., Al‐Serri, A., Alaskar, H., Al-Kandari, W. Y., & Al‐Bustan, S. A. (2019) · Lipids in Health and Disease · doi:10.1186/s12944-019-1165-6 · Cited by 8
Kuang, Y., Li, X., Chen, X., Sun, H., Tomlinson, B., Chan, P., Zheng, L., Pi, J., Peng, S., Wu, H., et al. (2016) · Scientific Reports · doi:10.1038/srep34268 · Cited by 7
Phyto-Enrichment of Yogurt to Control Hypercholesterolemia: A Functional Approach
Kumar, H., Bhardwaj, K., Martins, N. A., Sharma, R., Siddiqui, S. A., Dhanjal, D. S., Singh, R., Chopra, C., Dantas, A., Verma, R., et al. (2022) · Molecules · doi:10.3390/molecules27113479 · Cited by 7
García-Sánchez, E., Rubio‐Arias, J. Á., Ávila-Gandía, V., López-Román, F. J., & Menarguez-Puche, J. F. (2020) · Journal of Personalized Medicine · doi:10.3390/jpm10040176 · Cited by 12
Systematic Identification of Familial Hypercholesterolaemia in Primary Care—A Systematic Review
Silva, L., Qureshi, N., Abdul-Hamid, H., Weng, S. F., Kai, J., & Leonardi‐Bee, J. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11040302 · Cited by 7
Proteomic Analysis of Serum Lysine Acetylation in Uyghur Patients With T2DM
Yin, L., Feng, G. L., Huang, C., & Cai, W. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.787885 · Cited by 6
Li, L., Li, P., Yang, J., Huang, X. B., Bao, H., Zhang, C., Song, Y., Zhao, M., Ji, M., Wang, Y., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-07355-w · Cited by 6
EFEITO DO EXERCÍCIO SOBRE OS NÍVEIS DE HDL-C: UMA REVISÃO SISTEMÁTICA DE METANÁLISES
Fraga, A. S., Ladeia, A. M. T., de Sá, C. K. C., & Tenório, M. C. C. (2017) · Revista Brasileira de Medicina do Esporte · doi:10.1590/1517-869220172306163603 · Cited by 6
Shimizu, R., Torii, H., Yasuda, D., Hiraoka, Y., Kitada, N., Hashida, T., Yoshimoto, A., Kita, T., & Kume, N. (2015) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.29165 · Cited by 6
Kalay, F., Toprak, S., Ekmekçi, H., Kücür, M., İkitimur, B., Sönmez, H. A., & Güngör, Z. (2022) · Journal of Medical Biochemistry · doi:10.5937/jomb0-33855 · Cited by 5
Köenig, W., Marx, N., Thiery, J., & Klose, G. (2012) · Der Kardiologe · doi:10.1007/s12181-012-0420-0 · Cited by 5
Huang, Y., Yu, X.-Q., Millican, D., Wu, L., Shi, P., Lü, M., & Wu, Y. (2012) · Clinical Cardiology · doi:10.1002/clc.22015 · Cited by 5
Кутишенко, Н. П., Martsevich, S. Y., Lerman, O. V., Balashov, I. S., Афанасьевна, Н. В., Reznik, I. I., Shavkuta, G. V., & Yakhontov, D. A. (2015) · Rational Pharmacotherapy in Cardiology · doi:10.20996/1819-6446-2015-11-3-297-303 · Cited by 5
Honta, Z. M., Shylivskyi, I. V., Nemesh, O. M., & Burda, K. B. (2023) · Zaporozhye Medical Journal · doi:10.14739/2310-1210.2023.1.267456 · Cited by 5
Suematsu, Y., Miura, S., Zhang, B., Uehara, Y., Tokunaga, M., Yonemoto, N., Nonogi, H., Nagao, K., Kimura, T., & Saku, K. (2013) · IJC Heart & Vessels · doi:10.1016/j.ijchv.2013.11.002 · Cited by 5
Anti-inflammatoires non stéroïdiens et vaisseaux
Soubrier, M., Rosenbaum, D. H., Tatar, Z., Lahaye, C., Dubost, J., & Mathieu, S. (2013) · Revue du Rhumatisme · doi:10.1016/j.rhum.2012.11.012 · Cited by 4
Yoo, J. S., Han, K., Chung, S. H., & Park, E. (2019) · BMC Cancer · doi:10.1186/s12885-018-5196-6 · Cited by 4
Weintraub, W. S., & Arbab‐Zadeh, A. (2020) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2020.04.007 · Cited by 4
Kopčeková, J., Lorková, M., Habánová, M., Chlebo, P., Ferenčíková, Z., & Chlebová, Z. (2015) · Potravinarstvo Slovak Journal of Food Sciences · doi:10.5219/491 · Cited by 4
Assessment of Cardiovascular Risk in Patients with Rheumatoid Arthritis
Matteson, E. L., & Mankad, R. (2016) · The Journal of Rheumatology · doi:10.3899/jrheum.161025 · Cited by 4
Influence of cognitive function on cerebrovascular disease among the elderly
Guo, J. C., Sun, F., Tao, L., Luo, Y., Liu, L., Cao, K., Li, H., Tang, Z., & GUO, X. (2016) · Acta Neurologica Scandinavica · doi:10.1111/ane.12599 · Cited by 3
Tomilova, D. I., IuA, K., & Лопухова, В. В. (2017) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2017-8-7-12 · Cited by 3
Mancera-Rincón, P., Giral-Giraldo, H. E., Rizo-Tello, V. Z., & Barrera-Garavito, E. C. (2018) · Acta Médica Colombiana · doi:10.36104/amc.2018.1269 · Cited by 3
Semenova, A. А., Merkulova, I. N., Shariya, M. A., Barysheva, N. A., Kolesnikova, O. G., Zhukova, N. S., Sukhinina, T. S., Shakhnovich, R. M., Анатольевна, Г. С., Veselova, T. N., et al. (2021) · Russian Cardiology Bulletin · doi:10.17116/cardiobulletin20211604166 · Cited by 3
Melnikova, E. A., Avdeeva, I. V., & Oleynikov, V. E. (2016) · Современные технологии в медицине · doi:10.17691/stm2016.8.2.16 · Cited by 3
Secondary prevention of heart disease and stroke: work to do
Heagerty, A. M. (2011) · The Lancet · doi:10.1016/s0140-6736(11)61302-0 · Cited by 3
Brinton, E. A., Triscari, J. M., Brudi, P., Chen, E., Johnson‐Levonas, A. O., Sisk, C. M., Ruck, R. A., MacLean, A. A., Maccubbin, D., & Mitchel, Y. (2016) · Lipids in Health and Disease · doi:10.1186/s12944-016-0282-8 · Cited by 3
Chronic kidney disease: definition, classification, diagnostics, and treatment
Kobalava, Z. D., Вадимовна, В. С., & Алексеевна, Е. М. (2013) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2013-4-95-103 · Cited by 3
Bruckert, É., Désaméricq, G., Khachatryan, A., Ngo, P., Gusto, G., & Sorio-Vilela, F. (2020) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm.2020.04.189 · Cited by 4
Luo, G., Chen, W., Luo, J., & Liu, J. (2021) · Micro & Nano Letters · doi:10.1049/mna2.12081 · Cited by 3
Perioperativer Umgang mit der Dauermedikation bei kardialen Vorerkrankungen
Ninke, T., & Kilger, E. (2021) · AINS - Anästhesiologie · Intensivmedizin · Notfallmedizin · Schmerztherapie · doi:10.1055/a-1226-4720 · Cited by 3
Tratamiento combinado: pautas, indicaciones y perfil de seguridad
Muñiz-Grijalvo, O., & Ortiz, J. V. (2013) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/j.arteri.2013.06.003 · Cited by 2
Georgiopoulos, G. A., Karatzi, K., Euthimiou, E., Laina, A., Kontogiannis, C., Mareti, A., Mavroeidis, I., Kouzoupis, A. V., Mitrakou, A., Papamichael, C. M., et al. (2018) · European Journal of Nutrition · doi:10.1007/s00394-018-1781-3 · Cited by 2
Дзугкоев, С. Г., Garmash, O. Y., & Дзугкоева, Ф. С. (2021) · CARDIOVASCULAR THERAPY AND PREVENTION · doi:10.15829/1728-8800-2021-2793 · Cited by 3
Amalia, R., & Syauqy, A. (2014) · Journal of Nutrition College · doi:10.14710/jnc.v3i4.6882 · Cited by 2
Кожокарь, К. Г., & Александровна, У. И. (2017) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2017-5-97-103 · Cited by 2
Rohani, A. S., Yuandani, Y., & Sitorus, P. (2020) · IOP Conference Series Earth and Environmental Science · doi:10.1088/1755-1315/454/1/012103 · Cited by 2
Update Fettstoffwechselstörungen
Parhofer, K. G. (2013) · Der Internist · doi:10.1007/s00108-013-3335-3 · Cited by 2
Management of dyslipidemia in diabetic patients: The situation in primary health care units
Fonseca, D. A., Lamas, J., & Duarte, L. L. (2022) · Revista Portuguesa de Cardiologia · doi:10.1016/j.repc.2021.02.013 · Cited by 2
Imburgio, S., Vedire, A., Sanekommu, H., Johal, A. S., Taj, S., Lesniak, C., & Mushtaq, A. (2023) · Case Reports in Endocrinology · doi:10.1155/2023/9122669 · Cited by 3
Beaufrère, H. (2013) · Civil War Book Review · doi:10.31390/gradschool_dissertations.1598
THE REVOLUTION, WE HAVE ALMOST OVERSLEPT
Zateyshchikov, D. A., & Monserrat, L. (2015) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2015-10-7-11 · Cited by 1
Dyslipidemia in patients with Multiple Sclerosis and its correlation with disease parameters
Mahmoud, H. B., Tawfek, M. H., Yamani, E., & Zaher, M. (2023) · Egyptian Journal of Medical Research · doi:10.21608/ejmr.2022.113515.1177 · Cited by 2
Farsani, A. M., & Dhanaraju, M. D. (2025) · Balneo and PRM Research Journal · doi:10.12680/balneo.2025.770 · Cited by 1
Windler, E. E. T., & Zyriax, B. (2015) · Atherosclerosis Supplements · doi:10.1016/j.atherosclerosissup.2015.02.027 · Cited by 1
Elis, A. (2012) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.12.39 · Cited by 1
Teramoto, T., Sasaki, J., Ishibashi, S., Birou, S., Daida, H., Dohi, S., Egusa, G., Hiro, T., Hirobe, K., Iida, M., et al. (2013) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.19679 · Cited by 1
Dyslipidemia and Cardiovascular Risk in Obesity
Arca, M. (2014) · Springer eBooks · doi:10.1007/978-3-319-09045-0_12 · Cited by 1
INNOVATIONS IN DIAGNOSTICS AND TREATMENT OF PATIENTS WITH HYPERTRIGLYCERIDEMIA
Симерзин, В. В., Fatenkov, O. V., Gagloeva, I. V., Galkina, M. A., Panisheva, Y. A., & Krasovskaya, M. A. (2017) · Science and Innovations in Medicine · doi:10.35693/2500-1388-2017-0-1-43-51 · Cited by 1
Zuki, A. H. M., & Isa, M. R. (2022) · Journal of Public Health Issues and Practices · doi:10.33790/jphip1100198 · Cited by 1
DUBE, M., Singh, A., & KHARE, N. (2022) · Asian Journal of Pharmaceutical and Clinical Research · doi:10.22159/ajpcr.2022.v15i8.45438 · Cited by 1
Update on Comorbidities in Psoriasis
Andersson, A., Skov, L., Thyssen, J. P., & Egeberg, A. (2017) · Current Dermatology Reports · doi:10.1007/s13671-017-0171-z · Cited by 1
Strategies for identifying familial hypercholesterolaemia in non-specialist clinical settings
Qureshi, N., Weng, S. F., Tranter, J., Silva, M. L. D., Kai, J., & Leonardi‐Bee, J. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012985 · Cited by 1
Participants with Treated Hyperlipidemia may be More Health Conscious
Hozawa, A., & Okamura, T. (2015) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.ed021
Faut-il donner des statines à tous les lupiques ?
Soubrier, M., Mathieu, S., Hermet, M., Makarawiez, C., & Bruckert, É. (2012) · Revue du Rhumatisme · doi:10.1016/j.rhum.2012.07.015
Statins are better than fibrates in patients with a previous venous thromboembolism
Squizzato, A., Guasti, L., & Ageno, W. (2012) · Thrombosis Research · doi:10.1016/j.thromres.2012.09.016
Soylu, K. (2013) · Journal of Experimental and Clinical Medicine · doi:10.5835/jecm.omu.29.s3.004
Profile of plasma lipids and degree of derangements among the elderly of Morogoro region, Tanzania
Mwangengwa, L. M., John, J., Elfuraha, B., Werema, C. J., Mushi, J. R., Mohamed, A. H., Ngarashi, D., & Mpanduji, D. G. (2014) · Tanzania journal of health research/Tanzania Journal of Health Research · doi:10.4314/thrb.v16i4.2
Neue Entwicklungen in der Lipidtherapie
Parhofer, K. G. (2012) · Der Diabetologe · doi:10.1007/s11428-012-0892-3
Primary dyslipidemia and cardiometabolic risk: potential of pitavastatin.
Berezin, A. Е., Sheychenko, T. V., Berezina, T. A., Vishnevaya, N. V., Kovalenko, N. V., Кулик, З. И., & Моисеенко, И. А. (2015) · Medicni perspektivi · doi:10.26641/2307-0404.2015.2.45652
Pharmacological management of cardiovascular disease in patients with rheumatoid arthritis
Rollefstad, S., Ikdahl, E., & Semb, A. G. (2016) · Springer eBooks · doi:10.1007/978-3-319-26782-1_5
Traitement médicamenteux du syndrome coronarien aigu du sujet âgé
Rifai, R., & Assayag, P. (2015) · Archives des Maladies du Coeur et des Vaisseaux - Pratique · doi:10.1016/j.amcp.2015.06.009
The changing paradigm of dyslipidaemia management
Ekanayaka, R. (2017) · Universa Medicina · doi:10.18051/univmed.2017.v36.1-3
HYPERCHOLESTEROLEMIA: TWELVE MYTHS IN PRACTICE OF INTERNIST
Rodionov, A. V., & Габитова, М. А. (2016) · Meditsinskiy sovet = Medical Council · doi:10.21518/2079-701x-2016-19-145-149
Correa, M. L. M. (2017) · UVaDOC UVaDOC University of Valladolid Documentary Repository (University of Valladolid) · doi:10.35376/10324/25762
Fettstoffwechsel; Lipidsenker - Pharmakotherapie bei Fettstoffwechselstörungen
Keller, C. (2013) · Elsevier eBooks · doi:10.1016/b978-3-437-42523-3.00025-7
Статины в нефрологии: что говорят руководства?
Ivanov, D. D. (2022) · KIDNEYS · doi:10.22141/2307-1257.0.4.06.2013.85391
Faut-il donner des statines à tous les lupiques ?
Soubrier, M., Mathieu, S., & Bruckert, É. (2013) · Elsevier eBooks · doi:10.1016/b978-2-294-71447-4.50025-8
Familial Hypercholesterolaemia: An Updated Overall Management
Kasim, N. A. M., Chua, Y. A., & Nawawi, H. M. (2020) · Journal of Clinical and Health Sciences · doi:10.24191/jchs.v5i2.11121
Statin therapy and atherosclerosis stabilization in carotid arteries
Лугинова, З. Г., Koshurnikova, M., Solovieva, E., Balakhonova, T. V., & Susekov, A. V. (2015) · Cardiosomatics · doi:10.26442/cs45136
Bai, Z., Xu, M., Mei, Y., Hu, T., Zhang, P., Chen, M., Lv, W., Lü, C., & Tan, S. (2021) · Research Square · doi:10.21203/rs.3.rs-957578/v1
Prevalence and Related Factors of Dyslipidemia among Adults Aged 35 to 79 years in Southwest ChinaPreprint
Huang, C., Zhang, W., Tang, W., Liu, Y., Liu, J.-X., Xu, R., Zhao, S.-P., Wang, T.-D., & Huang, X.-B. (2021) · Research Square · doi:10.21203/rs.3.rs-139636/v1
Kostholdsråd ved høye blodlipider
Øyri, L. K. L., Johansen, D., Holven, K. B., Bogsrud, M. P., Ellingvåg, A., & Strøm, E. (2016) · Norsk tidsskrift for ernæring · doi:10.18261/ntfe.14.2.8
Galinovskaya, N. V., Усова, Н. Н., & Latysheva, V. Y. (2013) · Health and Ecology Issues · doi:10.51523/2708-6011.2013-10-4-4
Influence of surface steroid groups on sorption of salts of bile acids by mesoporous organosilicas
Roik, N. V., & Belyakova, L. A. (2023) · Himia Fizika ta Tehnologia Poverhni · doi:10.15407/hftp14.03.324
Addressing barriers to human capital accumulation: Essays in development and health economics
Ochmann, S. (2023) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-10212
Особливості розвитку проатерогенних порушень у жінок з різним репродуктивним статусом
Спасьонова, Л. Г., Dmytruk, S. M., Medvedeva, I. M., & Dmytruk, S. A. (2013) · Likarska sprava · doi:10.31640/ls-2013-1-06
Moriarty, P. M., & Santos, R. D. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-28786-9.00038-4
Addressing barriers to human capital accumulation: Essays in development and health economics
Ochmann, S. (2023) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-10485
The lipid-lowering therapy effectiveness and IHD course after coronary stenting
Skoromna, A., Хомич, А. В., Романенко, С. В., & Koval', O. A. (2013) · Medicni perspektivi · doi:10.26641/2307-0404.2013.2.15947
Guo, X., Li, R., & Gao, J. (2026) · Women s Health Reports · doi:10.1177/26884844261421495
Vergès, B. L. (2026) · EMC - Endocrinologie - Nutrition · doi:10.1016/s1155-1941(24)48948-8
Hourcade‐Potelleret, F. (2012) · theses.fr (ABES) · doi:10.70675/e78e3f4az1aadz47d6z9a8bz8dd0e636d743
Role of Wnt5a in lysosoma l function : intracellular cholesterol accumulation and atherosclerosis
Awan, S. (2019) · theses.fr (ABES) · doi:10.70675/c7de7e4azdc16z4d22zbf82z586da191a349
Le rôle du récepteur aux LDL et de PCSK9 dans le diabète de type 2
Ramin‐Mangata, S. (2020) · theses.fr (ABES) · doi:10.70675/26622ba5zb0fcz4d30za6e6z5c95a0b5a33d
Adalimumab biosimilar-induced hypertriglyceridemia in psoriasis
Tabanelli, M., Olivoni, G., & Savoia, F. (2026) · Italian Journal of Dermatology and Venereology · doi:10.23736/s2784-8671.26.08530-0
Metadata
- Authors
- Catapano, A. L., Reiner, Ž., De Backer, G., Graham, I., Taskinen, M.-R., Wiklund, O., Agewall, S., Alegria, E., Chapman, M. J., Durrington, P., Erdine, S., Halcox, J., Hobbs, R., Kjekshus, J., Perrone Filardi, P., Riccardi, G., Storey, R. F., & Wood, D.
- Corresponding author
- Catapano, Alberico L.
- Reiner, Željko
- ORCID
- Venue
- Atherosclerosis
- Publisher
- Elsevier BV
- Published
- 2011-07
- Volume
- 217
- Pages
- 1-44
- ISSN
- 0021-9150 (ISSN-L)
- OpenAlex
- W4210968492
- Cited by
- 192
- References
- 222
- Citations by year
- 2026: 3 · 2025: 1 · 2023: 7 · 2022: 12 · 2021: 11 · 2020: 11 · 2019: 6 · 2018: 8 · 2017: 13 · 2016: 29 · 2015: 27 · 2014: 10 · 2013: 34 · 2012: 16
- FWCI
- 3.63
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Atherosclerosis (publishedVersion)
- PubMed (publishedVersion)
- ORBi (University of Liège) (submittedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Clinical practice guidelines implementation
- Keywords
- dyslipidemia, dyslipidemia management, lipid-lowering therapy, cardiovascular risk, risk-benefit assessment, clinical guidelines
- MeSH terms
- Adolescent, Adult, Aged, Cardiology, Cardiovascular Diseases, Child, Cholesterol, Clinical Trials as Topic, Europe, Female, Genotype, Humans, Life Style, Lipids, Lipoproteins, Male, Middle Aged, Societies, Medical, Practice Guidelines as Topic, Dyslipidemias, Atherosclerosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review